Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$50.62 - $56.47 $25,310 - $28,235
-500 Reduced 1.85%
26,500 $1.47 Million
Q2 2021

Aug 13, 2021

SELL
$46.28 - $52.75 $9,256 - $10,550
-200 Reduced 0.74%
27,000 $1.31 Million
Q1 2021

May 14, 2021

SELL
$46.25 - $56.02 $508,750 - $616,220
-11,000 Reduced 28.8%
27,200 $1.32 Million
Q4 2020

Feb 05, 2021

SELL
$46.09 - $54.74 $1.05 Million - $1.25 Million
-22,800 Reduced 37.38%
38,200 $2.02 Million
Q3 2020

Nov 06, 2020

SELL
$42.51 - $52.42 $956,475 - $1.18 Million
-22,500 Reduced 26.95%
61,000 $3.19 Million
Q2 2020

Aug 13, 2020

BUY
$39.49 - $44.36 $213,246 - $239,544
5,400 Added 6.91%
83,500 $3.58 Million
Q1 2020

May 14, 2020

BUY
$33.17 - $41.6 $2.59 Million - $3.25 Million
78,100 New
78,100 $3.25 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.46B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.